Noninvasive Diagnostics in Left Ventricular Assist Device Patients

Not Applicable

Active, not recruiting

• Conditions: Artificial Heart Device User; Heart Failure
• Interventions: Other: Recording of LVAD data during routine visits and daily life.; Other: Recording of daily activity using wristwatch accelerometers.

• Registration Number: NCT01981642
• Lead Sponsor: Medical University of Vienna

Brief Summary

* Study Purpose: The purpose of this study is to evaluate the sensitivity/specificity of noninvasive diagnostic methods for the cardiac function that are based on data available from the Left Ventricular Assist Device (LVAD). These diagnostic methods will be compared to standard clinical diagnostic procedures both at rest and during exercise.

* Study Design: The study is a prospective interventional cohort study.

* Patient cohort: Thirty heart failure patients who had or are about to have a LVAD implanted.

* Data Collection: The acquisition of LVAD data (motor current and speed) and wristwatch accelerometry data concurrently to the documentation of routine clinical examinations, such as cardiac ultrasound, electrocardiography (ECG), cardiac catheterization, and exercise tests, will be performed.

Detailed Description

* Background: In recent years Left Ventricular Assist Devices (LVADs) have become the devices of choice to treat patients with advanced heart failure. Proper evaluation of the cardiovascular function under LVAD support is of key importance especially for the preservation of the assisted cardiac function or for the evaluation of an eventual cardiac recovery. Cardiac echocardiography, electrocardiography and catheterization, as well as exercise testing are the standard clinical methods for the evaluation of the cardiovascular function during LVAD support. All these methods require however time-consuming procedures, and are therefore unacceptably cumbersome for frequent monitoring. On the other hand, a frequent and effective noninvasive evaluation of the cardiac status provided by the LVAD itself would have a remarkable impact on LVAD patients and their therapy. Previously developed methods to assess the cardiovascular status from data available from the LVAD (see references given) will be now investigated in a prospective clinical study.

* Purpose: The main purpose of this study is evaluate the sensitivity/specificity of LVAD based diagnostics when compared to standard clinical diagnostic procedures both at rest and during exercise. Secondarily, the physical activity of patients will be evaluated following LVAD implantation.

* Methods: Seventy-five heart failure patients who had or are about to have a LVAD implanted will be enrolled in this study. In these patients, the LVAD data (motor current and speed) will be recorded concurrently to the routine clinical examinations and during daily life. The routine clinical examinations typically consist of a subset of the following procedures: cardiac ultrasound, cardiac catheterization, 24h ECG measurement, exercise tests (6-minute walk test and spiroergometry). Parameters from the LVAD data that reflect contractile and relaxation properties as well as and aortic valve opening will be compared to echocardiography. Parameters from the LVAD data that reflect cardiac rhythms will be compared to ECG measurements. Both cardiac hemodynamics and rhythms during exercise tests will be assessed using the developed methods based on LVAD data. Finally, wristwatch accelerometers will be used for a quantification and evaluation of patient daily life activity. This measurements will be compared to 6-minute walk test and spiroergometry data as well as with the diagnostics methods based on the LVAD data.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2011-12
• Study First Submitted: 2013-10-29
• Study First Submitted QC: 2013-11-05
• Study First Posted: 2013-11-11
• Status Verified: 2023-10
• Last Update Submitted: 2023-10-20
• Last Update Posted: 2023-10-23
• Primary Completion: 2024-12

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Signed informed consent obtained from the subject prior to participation;
• At least 18 years of age and maximum 70 years old;
• Subjects who received or are about to receive an LVAD.

Read More

Exclusion Criteria

• Coagulation system disorders;
• Pregnant or breast-feeding women;
• Patients with bi-ventricular assist devices.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Patients with a LVAD implanted.	Recording of LVAD data during routine visits and daily life.	Recording of LVAD data during routine visits and daily life. Recording of daily activity using wristwatch accelerometers.
Patients with a LVAD implanted.	Recording of daily activity using wristwatch accelerometers.	Recording of LVAD data during routine visits and daily life. Recording of daily activity using wristwatch accelerometers.

Primary Outcome Measures

Name	Time	Method
Sensitivity/specificity of LVAD-based methods to monitor the cardiovascular function when compared to routine clinical diagnostics.	Participants will be followed for the duration of LVAD implant, an expected average of 2 years.

Secondary Outcome Measures

Name	Time	Method
Documentation of daily life activities as measured using wristwatch accelerometers and routine clinical exercise tests.	Participants will be followed for the duration of LVAD implant, an expected average of 2 years.

Trial Locations

Locations (1)

General Hospital / Medical University of Vienna; 🇦🇹 Vienna, Austria